Watchlist Price Alert

Eiger BioPharmaceuticals ... (EIGR)

NASDAQ: EIGR · Real-Time Price · USD

1.73

0.00 (0.29%)

At close: Apr 03, 2024, 3:59 PM

Eiger BioPharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	25.44M	25.8M	22.22M	28.86M	39.37M	61.26M	32.03M	27.76M
Short-Term Investments	n/a	73.15M	66.59M	99.98M	55.62M	39.09M	9.74M	32.18M
Long-Term Investments	n/a	n/a	17.26M	n/a	n/a	n/a	n/a	65K
Other Long-Term Assets	360K	1.22M	4.51M	3.66M	2.51M	436K	312K	78K
Receivables	1.68M	1.75M	2.58M	n/a	n/a	n/a	n/a	n/a
Inventory	1.56M	2.85M	2.61M	93K	n/a	n/a	n/a	n/a
Other Current Assets	1.29M	1.74M	1.26M	1.12M	5.39M	1.49M	712K	581K
Total Current Assets	37.84M	117.53M	103.36M	137.81M	100.38M	101.84M	42.49M	60.52M
Property-Plant & Equipment	627K	1.26M	1.27M	1.89M	2.24M	167K	79K	76K
Goodwill & Intangibles	n/a	n/a	-137K	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	987K	2.6M	23.04M	5.79M	4.75M	603K	391K	219K
Total Assets	38.83M	120.14M	126.4M	143.59M	105.14M	102.45M	42.88M	60.74M
Account Payables	2.12M	8.97M	7.76M	4.64M	6.41M	5.83M	3.18M	2.64M
Deferred Revenue	n/a	1.37M	1.85M	n/a	n/a	n/a	56K	n/a
Short-Term Debt	41.12M	n/a	7.81M	582K	534K	n/a	2M	n/a
Other Current Liabilities	5.32M	7.54M	4.98M	2.59M	1.17M	1.71M	1.26M	1.3M
Total Current Liabilities	53.28M	25.12M	29.9M	16.63M	16.95M	10.02M	7.27M	5.29M
Long-Term Debt	n/a	39.63M	23.99M	31.19M	30.39M	25.62M	13.09M	14.73M
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	212K	n/a	n/a
Total Long-Term Liabilities	n/a	39.71M	24.1M	31.93M	31.71M	25.83M	13.09M	14.73M
Total Liabilities	53.28M	64.83M	54M	48.56M	48.66M	35.86M	20.36M	20.02M
Total Debt	41.2M	40.2M	32.54M	32.51M	32.24M	25.62M	15.09M	14.73M
Common Stock	1K	44K	35K	34K	24K	19K	11K	8K
Retained Earnings	-512.16M	-437.19M	-340.42M	-306.5M	-241.45M	-171.2M	-118.81M	-76.36M
Comprehensive Income	-169K	-300K	-149K	-8K	42K	-25K	-3K	-15K
Shareholders Equity	-14.46M	55.31M	72.4M	95.03M	56.48M	66.59M	22.52M	40.72M
Total Investments	n/a	73.15M	83.86M	99.98M	55.62M	39.09M	9.74M	32.18M